Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
33
SBC Quote, Financials, Valuation and Earnings
Last price:
$6.13
Seasonality move
:
--
Day range:
$6.03 - $6.39
52-week range:
$5.21 - $12.50
Dividend yield:
0%
P/E ratio:
14.15x
P/S ratio:
2.86x
P/B ratio:
3.12x
Volume:
42.5K
Avg. volume:
75.9K
1-year change:
--
Market cap:
$639.8M
Revenue:
$193.5M
EPS (TTM):
$0.44
Analysts' Opinion
-
Consensus RatingSBC Medical Group Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, SBC Medical Group Holdings has an estimated upside of 77.13% from its current price of $6.21.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $6.21.
Fair Value
-
According to the consensus of 0 analysts, SBC Medical Group Holdings has 77.13% upside to fair value with a price target of -- per share.
SBC vs. S&P 500
-
Over the past 5 trading days, SBC Medical Group Holdings has overperformed the S&P 500 by 9.43% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
SBC Medical Group Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SBC Medical Group Holdings has grown year-over-year revenues for 0 quarters straight. In the most recent quarter SBC Medical Group Holdings reported revenues of $53.1M.
Earnings Growth
-
SBC Medical Group Holdings has grown year-over-year earnings for 0 quarters straight. In the most recent quarter SBC Medical Group Holdings reported earnings per share of $0.03.
Enterprise value:
525.6M
EV / Invested capital:
2.30x
Price / LTM sales:
2.86x
EV / EBIT:
6.19x
EV / Revenue:
2.44x
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
6.01x
Gross Profit (TTM):
$159.5M
Return On Assets:
16.29%
Net Income Margin (TTM):
20.4%
Return On Equity:
25.89%
Return On Invested Capital:
23.01%
Operating Margin:
26.06%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | $215.8M | $47.3M | $53.1M | |
| Gross Profit | -- | -- | $159.5M | $33.5M | $43.2M | |
| Operating Income | -- | -- | $85.2M | $20.1M | $13.8M | |
| EBITDA | -- | -- | $87.4M | $21.1M | $13.1M | |
| Diluted EPS | -- | -- | $0.44 | $0.08 | $0.03 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | $202.1M | |
| Total Assets | -- | -- | -- | -- | $296.5M | |
| Current Liabilities | -- | -- | -- | -- | $72.4M | |
| Total Liabilities | -- | -- | -- | -- | $91M | |
| Total Equity | -- | -- | -- | -- | $205.5M | |
| Total Debt | -- | -- | -- | -- | $22.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $22.8M | $27.9M | |
| Cash From Investing | -- | -- | -- | $8.7M | -$5.6M | |
| Cash From Financing | -- | -- | -- | $6.3M | $11.6M | |
| Free Cash Flow | -- | -- | -- | $18.4M | $25.1M | |
SBC
Sector
Market Cap
$639.8M
$44.6M
Price % of 52-Week High
49.68%
45.71%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.68%
1-Year Price Total Return
--
-29.09%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$6.07
200-day SMA
Buy
Level
$0.00
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
-3.2M
20-day SMA
Sell
Level
$6.41
Relative Strength Index (RSI14)
Sell
Level
46.48
ADX Line
Sell
Level
8.91
Williams %R
Neutral
Level
-41.5205
50-day SMA
Sell
Level
$6.77
MACD (12, 26)
Sell
Level
-0.19
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
1.2M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Buy
CA Score
(Annual)
Level (1.2692)
--
Beneish M-Score
(Annual)
Level (--)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.6647)
--
Piotroski F Score
(Annual)
Level (--)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). They provide management services to a total of One hundred fifty eight franchisee treatment centers under the brand name Shonan Beauty Clinic located in Japan.
Stock Forecast FAQ
In the current month, SBC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SBC average analyst price target in the past 3 months is --.
-
Where Will SBC Medical Group Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that SBC Medical Group Holdings share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About SBC Medical Group Holdings?
Analysts are divided on their view about SBC Medical Group Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SBC Medical Group Holdings is a Sell and believe this share price will drop from its current level to --.
-
What Is SBC Medical Group Holdings's Price Target?
The price target for SBC Medical Group Holdings over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SBC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SBC Medical Group Holdings is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SBC?
You can purchase shares of SBC Medical Group Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SBC Medical Group Holdings shares.
-
What Is The SBC Medical Group Holdings Share Price Today?
SBC Medical Group Holdings was last trading at $6.13 per share. This represents the most recent stock quote for SBC Medical Group Holdings. Yesterday, SBC Medical Group Holdings closed at $6.21 per share.
-
How To Buy SBC Medical Group Holdings Stock Online?
In order to purchase SBC Medical Group Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
